{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T02:58:31Z","timestamp":1778554711897,"version":"3.51.4"},"reference-count":27,"publisher":"Japanese Society of Toxicology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2018]]},"DOI":"10.2131\/jts.43.257","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T22:19:13Z","timestamp":1522793953000},"page":"257-266","source":"Crossref","is-referenced-by-count":6,"title":["Nicotine and methyl vinyl ketone, major components of cigarette smoke extracts, increase protective amyloid-\u03b2 peptides in cells harboring amyloid-\u03b2 precursor protein"],"prefix":"10.2131","volume":"43","author":[{"given":"Yoichi","family":"Ohshima","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Kyoto Prefectural University of Medicine"},{"name":"Department of Neurology, Kyoto Yamashiro General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumi","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakazu","family":"Ibi","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misaki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Katsuyama","sequence":"additional","affiliation":[{"name":"Radioisotope Center, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Yabe-Nishimura","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Kyoto Prefectural University of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Araki, W., Kume, H., Oda, A., Tamaoka, A. and Kametani, F. (2009): IGF-1 promotes beta-amyloid production by a secretase-independent mechanism. Biochem. Biophys. Res. Commun., <b>380<\/b>, 111-114.","DOI":"10.1016\/j.bbrc.2009.01.044"},{"key":"2","doi-asserted-by":"crossref","unstructured":"Buckingham, S.D., Jones, A.K., Brown, L.A. and Sattelle, D.B. (2009): Nicotinic acetylcholine receptor signalling: roles in Alzheimer\u2019s disease and amyloid neuroprotection. Pharmacol. Rev., <b>61<\/b>, 39-61.","DOI":"10.1124\/pr.108.000562"},{"key":"3","doi-asserted-by":"crossref","unstructured":"De Strooper, B. (2014): Lessons from a failed \u03b3-secretase Alzheimer trial. Cell, <b>159<\/b>, 721-726.","DOI":"10.1016\/j.cell.2014.10.016"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Doody, R.S., Raman, R., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., He, F., Sun, X., Thomas, R.G., Aisen, P.S., Siemers, E., Sethuraman, G. and Mohs, R.; Alzheimer\u2019s Disease Cooperative Study Steering Committee; Semagacestat Study Group. (2013): A phase 3 trial of semagacestat for treatment of Alzheimer\u2019s disease. N. Engl. J. Med., <b>369<\/b>, 341-350.","DOI":"10.1056\/NEJMoa1210951"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D. and Nakagawa, M. (2010): High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J., <b>24<\/b>, 2716-2726.","DOI":"10.1096\/fj.09-150359"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Gibbons, A. and Dean, B. (2016): The Cholinergic System: An Emerging Drug Target for Schizophrenia. Curr. Pharm. Des., <b>22<\/b>, 2124-2133.","DOI":"10.2174\/1381612822666160127114010"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Hardy, J. and Selkoe, D.J. (2002): The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science, <b>297<\/b>, 353-356.","DOI":"10.1126\/science.1072994"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Hardy, J.A. and Higgins, G.A. (1992): Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science, <b>256<\/b>, 184-185.","DOI":"10.1126\/science.1566067"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Inestrosa, N.C., Godoy, J.A., Vargas, J.Y., Arrazola, M.S., Rios, J.A., Carvajal, F.J., Serrano, F.G. and Farias, G.G. (2013): Nicotine prevents synaptic impairment induced by amyloid-\u03b2 oligomers through \u03b17-nicotinic acetylcholine receptor activation. Neuromolecular Med., <b>15<\/b>, 549-569.","DOI":"10.1007\/s12017-013-8242-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Kasai, T., Tokuda, T., Taylor, M., Kondo, M., Mann, D.M., Foulds, P.G., Nakagawa, M. and Allsop, D. (2013): Correlation of A\u03b2 oligomer levels in matched cerebrospinal fluid and serum samples. Neurosci. Lett., <b>551<\/b>, 17-22.","DOI":"10.1016\/j.neulet.2013.06.029"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kasai, T., Tokuda, T., Taylor, M., Nakagawa, M. and Allsop, D. (2012): Utilization of a multiple antigenic peptide as a calibration standard in the BAN50 single antibody sandwich ELISA for A\u03b2 oligomers. Biochem. Biophys. Res. Commun., <b>422<\/b>, 375-380.","DOI":"10.1016\/j.bbrc.2012.04.146"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Kihara, T., Shimohama, S., Urushitani, M., Sawada, H., Kimura, J., Kume, T., Maeda, T. and Akaike, A. (1998): Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res., <b>792<\/b>, 331-334.","DOI":"10.1016\/S0006-8993(98)00138-3"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Lee, M.S., Kao, S.C., Lemere, C.A., Xia, W., Tseng, H.C., Zhou, Y., Neve, R., Ahlijanian, M.K. and Tsai, L.H. (2003): APP processing is regulated by cytoplasmic phosphorylation. J. Cell Biol., <b>163<\/b>, 83-95.","DOI":"10.1083\/jcb.200301115"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Lombardo, S. and Maskos, U. (2015): Role of the nicotinic acetylcholine receptor in Alzheimer\u2019s disease pathology and treatment. Neuropharmacology, <b>96 (Pt B)<\/b>, 255-262.","DOI":"10.1016\/j.neuropharm.2014.11.018"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Muresan, V. and Ladescu Muresan, Z. (2015): Amyloid-\u03b2 precursor protein: multiple fragments, numerous transport routes and mechanisms. Exp. Cell Res., <b>334<\/b>, 45-53.","DOI":"10.1016\/j.yexcr.2014.12.014"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Nie, H.Z., Li, Z.Q., Yan, Q.X., Wang, Z.J., Zhao, W.J., Guo, L.C. and Yin, M. (2011): Nicotine decreases beta-amyloid through regulating BACE1 transcription in SH-EP1-\u03b14\u03b22 nAChR-APP695 cells. Neurochem. Res., <b>36<\/b>, 904-912.","DOI":"10.1007\/s11064-011-0420-7"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Nilsson, P., Saito, T. and Saido, T.C. (2014): New Mouse Model of Alzheimer\u2019s. ACS Chem. Neurosci., <b>5<\/b>, 499-502.","DOI":"10.1021\/cn500105p"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Ono, K., Hasegawa, K., Yamada, M. and Naiki, H. (2002): nicotine breaks down preformed Alzheimer\u2019s beta-amyloid fibrils <i>in vitro.<\/i> Biol. Psychiatry, <b>52<\/b>, 880-886.","DOI":"10.1016\/S0006-3223(02)01417-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Saido, T.C. (2013): Metabolism of amyloid \u03b2 peptide and pathogenesis of Alzheimer\u2019s disease. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci., <b>89<\/b>, 321-339.","DOI":"10.2183\/pjab.89.321"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Saito, T., Matsuba, Y., Mihira, N., Takano, J., Nilsson, P., Itohara, S., Iwata, N. and Saido, T.C. (2014): Single App knock-in mouse models of Alzheimer\u2019s disease. Nat. Neurosci., <b>17<\/b>, 661-663.","DOI":"10.1038\/nn.3697"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T.D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D. and Younkin, S. (1996): Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer\u2019s disease is increased <i>in vivo<\/i> by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer\u2019s disease. Nat. Med., <b>2<\/b>, 864-870.","DOI":"10.1038\/nm0896-864"},{"key":"22","first-page":"487","year":"1991","unstructured":"Selkoe, D.J. (1991): The molecular pathology of Alzheimer\u2019s disease. Neuron, <b>6<\/b>, 487-498.","journal-title":"Neuron","ISSN":"https:\/\/id.crossref.org\/issn\/0896-6273","issn-type":"print"},{"key":"23","doi-asserted-by":"publisher","unstructured":"Selkoe, D.J. (1997): Alzheimer\u2019s disease: genotypes, phenotypes, and treatments. Science, <b>275<\/b>, 630-631.","DOI":"10.1126\/science.275.5300.630"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Shaw, S., Bencherif, M. and Marrero, M.B. (2002): Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid. J. Biol. Chem., <b>277<\/b>, 44920-44924.","DOI":"10.1074\/jbc.M204610200"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Sodhi, C.P., Perez, R.G. and Gottardi-Littell, N.R. (2008): Phosphorylation of beta-amyloid precursor protein (APP) cytoplasmic tail facilitates amyloidogenic processing during apoptosis. Brain Res., <b>1198<\/b>, 204-212.","DOI":"10.1016\/j.brainres.2008.01.031"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Srivareerat, M., Tran, T.T., Salim, S., Aleisa, A.M. and Alkadhi, K.A. (2011): Chronic nicotine restores normal A\u03b2 levels and prevents short-term memory and E-LTP impairment in A\u03b2 rat model of Alzheimer\u2019s disease. Neurobiol. Aging, <b>32<\/b>, 834-844.","DOI":"10.1016\/j.neurobiolaging.2009.04.015"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Watanabe-Hosomi, A., Watanabe, Y., Tanaka, M., Nakagawa, M. and Mizuno, T. (2012): Transendocytosis is impaired in CADASIL-mutant NOTCH3. Exp. Neurol., <b>233<\/b>, 303-311.","DOI":"10.1016\/j.expneurol.2011.10.020"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/43\/4\/43_257\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T01:04:28Z","timestamp":1571015068000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/43\/4\/43_257\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.43.257","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}